Clinical trial
Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.
NCT05595681 · Cell to Cure ApS, Industry · Terminated
Key facts
| NCT number | NCT05595681 |
|---|---|
| Title | Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. |
| Official title | Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients. A Phase I Pilot Study. |
| Acronym | STEMFOOT |
| Lead sponsor | Cell to Cure ApS, Industry |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Diabetic Foot Ulcer, Mesenchymal Stromal Cells |
| Intervention type | Drug |
| Interventions | Adipose tissue derived mesenchymal stromal/stem cells (Cell2Cure®) |
| Enrollment | 21 |
| Start date | Dec 15, 2022 |
| Primary completion | Nov 28, 2025 |
| Completion | Nov 28, 2025 |
| First posted | Oct 27, 2022 |
| Last update posted | Dec 23, 2025 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: